Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201) [Phase 2]

View source ↗

Summary

The update describes results from a Phase 2 study evaluating the safety and effectiveness of ALKS 2680 in subjects with Narcolepsy Type 1, which has completed t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• ALKS 2680

Snippet

Sponsor: Alkermes, Inc. | Conditions: Narcolepsy Type 1 | Phase 2 | Status: COMPLETED